The topics listed, including alimta, avastin, cimzia, cladribine, and entyvio, are associated with various issues that affect their effectiveness and patient experience. For alimta, the issues include disease progression, such as multiple brain mets and leptomeningeal carcinomatosis, as well as bacterial infections and side effects from radiation and pain medicine. Avastin is linked to limited growth in brain mets, but also heart and mandibula metastasis. Cimzia is problematic due to difficulties with the infusion process, bruising and pain at the infusion site, and frustration with healthcare providers. Cladribine, on the other hand, is plagued by concerns about side effects, long waiting lists, and deterioration of symptoms, including walking and bladder control issues. Lastly, entyvio is associated with ineffectiveness, as seen in patients who have not responded to remicade, and pouchitis.

To address these issues, several suggestions can be made. Firstly, for alimta, a more comprehensive treatment plan that incorporates alternative therapies to manage bacterial infections and disease progression is necessary. Additionally, closer monitoring of side effects from radiation and pain medicine can help mitigate these issues. For avastin, further research into its effectiveness in reducing metastasis in various parts of the body is needed. Cimzia's infusion process could be improved through better training of healthcare providers and the development of more user-friendly infusion systems. Cladribine's efficacy and side effects need to be closely monitored, and alternative treatments should be considered for patients who experience significant deterioration of symptoms. Lastly, entyvio's ineffectiveness in certain patients warrants further investigation into its mechanism of action and potential alternatives for patients who do not respond to remicade. Overall, a multidisciplinary approach that incorporates patient feedback, medical research, and healthcare provider training is necessary to address the issues associated with these topics.